Portfolio von State of New Jersey Common Pension Fund D
1425 gemeldete Positionen · zum 31.03.2026
Originalmeldung · Zehn größte Positionen: 31.6 % des Aktienteils
Aufteilung nach Branche
- Technologie 24,6 %
- Finanzen 9,2 %
- Kommunikation 8,0 %
- Zyklischer Konsum 7,6 %
- Gesundheit 7,1 %
- Industrie 6,4 %
- Basiskonsum 3,9 %
- Fonds 3,0 %
- Energie 2,6 %
- Immobilien 2,3 %
- Versorger 1,8 %
- Rohstoffe 1,3 %
- Nicht zugeordnet 22,1 %
Einstufung von Titelia, Gesellschaft für Gesellschaft. Der nicht zugeordnete Anteil bleibt sichtbar.
Aufteilung nach Währung
- USD 100,0 %
Die gemeldete Notierungswährung jeder Position.
Länderaufteilung
- US 98,6 %
- IN 0,4 %
- BR 0,3 %
- MX 0,2 %
- CN 0,1 %
- ES 0,1 %
- IL 0,1 %
- KZ 0,1 %
- KR 0,0 %
- ID 0,0 %
- KY 0,0 %
- LU 0,0 %
Anteile berechnet auf den Aktienteil.
| Rang | Land | Positionen | Wert | Anteil |
|---|---|---|---|---|
| 1 | US | 1.397 | 24,6 Mrd. $ | 98,62 % |
| 2 | IN | 3 | 109,2 Mio. $ | 0,44 % |
| 3 | BR | 4 | 82,2 Mio. $ | 0,33 % |
| 4 | MX | 5 | 42,5 Mio. $ | 0,17 % |
| 5 | CN | 2 | 26,1 Mio. $ | 0,10 % |
| 6 | ES | 1 | 23,9 Mio. $ | 0,10 % |
| 7 | IL | 1 | 15,8 Mio. $ | 0,06 % |
| 8 | KZ | 1 | 14,6 Mio. $ | 0,06 % |
| 9 | KR | 1 | 10,5 Mio. $ | 0,04 % |
| 10 | ID | 1 | 7,4 Mio. $ | 0,03 % |
| 11 | KY | 2 | 4,5 Mio. $ | 0,02 % |
| 12 | LU | 1 | 3,7 Mio. $ | 0,01 % |
Positionen
| Rang | Gesellschaft | Stücke | Wert | Gewicht |
|---|---|---|---|---|
| 1.301 | Crinetics Pharmaceuticals Inc | 30.576 | 1,1 Mio. $ | |
| 1.302 | Cogent Biosciences Inc | 28.646 | 1,1 Mio. $ | |
| 1.303 | Arcellx Inc | 9.477 | 1,1 Mio. $ | |
| 1.304 | Scholar Rock Holding Corp | 21.354 | 1 Mio. $ | |
| 1.305 | Apellis Pharmaceuticals Inc | 25.896 | 1 Mio. $ | |
| 1.306 | Terns Pharmaceuticals Inc | 19.440 | 1 Mio. $ | |
| 1.307 | Supernus Pharmaceuticals Inc | 19.596 | 1 Mio. $ | |
| 1.308 | CG oncology Inc | 14.617 | 989.279 $ | |
| 1.309 | Catalyst Pharmaceuticals Inc | 39.737 | 983.888 $ | |
| 1.310 | Twist Bioscience Corp | 20.629 | 980.290 $ | |
| 1.311 | Eos Energy Enterprises Inc | 196.413 | 974.208 $ | |
| 1.312 | Prestige Consumer Healthcare Inc | 16.433 | 973.984 $ | |
| 1.313 | Erasca Inc | 58.176 | 941.288 $ | |
| 1.314 | Apogee Therapeutics Inc | 11.073 | 932.014 $ | |
| 1.315 | Denali Therapeutics Inc | 47.471 | 911.443 $ | |
| 1.316 | ImmunityBio Inc | 117.817 | 903.656 $ | |
| 1.317 | ACADIA Pharmaceuticals Inc | 40.473 | 900.929 $ | |
| 1.318 | Ideaya Biosciences Inc | 26.958 | 898.241 $ | |
| 1.319 | Arcutis Biotherapeutics Inc | 37.676 | 887.647 $ | |
| 1.320 | Veracyte Inc | 27.016 | 870.185 $ | |
| 1.321 | Travere Therapeutics Inc | 29.049 | 863.046 $ | |
| 1.322 | Spyre Therapeutics Inc | 16.720 | 843.357 $ | |
| 1.323 | Immunocore Holdings PLC | 27.663 | 834.039 $ | |
| 1.324 | Celcuity Inc | 7.116 | 812.220 $ | |
| 1.325 | Liquidia Corp | 20.812 | 785.445 $ | |
| 1.326 | Tarsus Pharmaceuticals Inc | 10.880 | 763.232 $ | |
| 1.327 | Beam Therapeutics Inc | 31.212 | 743.782 $ | |
| 1.328 | Sarepta Therapeutics Inc | 34.021 | 740.297 $ | |
| 1.329 | ADMA Biologics Inc | 81.337 | 732.846 $ | |
| 1.330 | Dyne Therapeutics Inc | 39.390 | 714.141 $ | |
| 1.331 | Immunome Inc | 32.052 | 700.977 $ | |
| 1.332 | Immunovant Inc | 27.542 | 684.143 $ | |
| 1.333 | BioCryst Pharmaceuticals Inc | 70.830 | 674.302 $ | |
| 1.334 | Amneal Pharmaceuticals Inc | 53.718 | 667.715 $ | |
| 1.335 | Syndax Pharmaceuticals Inc | 27.968 | 653.332 $ | |
| 1.336 | Celldex Therapeutics Inc | 20.439 | 648.325 $ | |
| 1.337 | Arcus Biosciences Inc | 29.600 | 639.360 $ | |
| 1.338 | Sila Realty Trust Inc | 27.000 | 639.360 $ | |
| 1.339 | Agios Pharmaceuticals Inc | 18.864 | 638.169 $ | |
| 1.340 | Ultragenyx Pharmaceutical Inc | 29.675 | 621.691 $ | |
| 1.341 | GRAIL Inc | 11.990 | 619.643 $ | |
| 1.342 | Clipper Realty Inc | 204.993 | 619.079 $ | |
| 1.343 | Nektar Therapeutics | 8.288 | 596.322 $ | |
| 1.344 | Park Hotels & Resorts Inc | 55.000 | 579.150 $ | |
| 1.345 | Edgewise Therapeutics Inc | 18.091 | 569.867 $ | |
| 1.346 | Innoviva Inc | 24.275 | 565.608 $ | |
| 1.347 | Apartment Investment and Management Co | 138.773 | 564.806 $ | |
| 1.348 | Vericel Corp | 17.284 | 556.026 $ | |
| 1.349 | Organon & Co | 88.851 | 532.217 $ | |
| 1.350 | Disc Medicine Inc | 8.317 | 531.789 $ | |
| 1.351 | Day One Biopharmaceuticals Inc | 24.563 | 526.631 $ | |
| 1.352 | Vera Therapeutics Inc | 13.087 | 526.490 $ | |
| 1.353 | Soleno Therapeutics Inc | 15.602 | 522.355 $ | |
| 1.354 | Capricor Therapeutics Inc | 16.733 | 508.683 $ | |
| 1.355 | Ardelyx Inc | 83.038 | 497.398 $ | |
| 1.356 | Alumis Inc | 22.087 | 486.577 $ | |
| 1.357 | Intellia Therapeutics Inc | 37.606 | 482.109 $ | |
| 1.358 | ANI Pharmaceuticals Inc | 6.140 | 472.166 $ | |
| 1.359 | Medical Properties Trust Inc | 100.999 | 467.625 $ | |
| 1.360 | Recursion Pharmaceuticals Inc | 151.428 | 464.884 $ | |
| 1.361 | Ocular Therapeutix Inc | 54.608 | 462.530 $ | |
| 1.362 | Dianthus Therapeutics Inc | 5.443 | 456.777 $ | |
| 1.363 | Stoke Therapeutics Inc | 13.664 | 444.900 $ | |
| 1.364 | Xenia Hotels & Resorts Inc | 30.000 | 444.900 $ | |
| 1.365 | Enliven Therapeutics Inc | 11.155 | 437.276 $ | |
| 1.366 | Viridian Therapeutics Inc | 22.269 | 435.582 $ | |
| 1.367 | Mineralys Therapeutics Inc | 15.604 | 422.712 $ | |
| 1.368 | Harmony Biosciences Holdings Inc | 14.747 | 413.063 $ | |
| 1.369 | Relay Therapeutics Inc | 41.464 | 412.567 $ | |
| 1.370 | Nurix Therapeutics Inc | 25.983 | 402.737 $ | |
| 1.371 | Phibro Animal Health Corp | 6.988 | 386.506 $ | |
| 1.372 | Novavax Inc | 47.205 | 384.249 $ | |
| 1.373 | Harrow Inc | 10.759 | 379.362 $ | |
| 1.374 | Kodiak Sciences Inc | 9.929 | 378.493 $ | |
| 1.375 | Iovance Biotherapeutics Inc | 105.116 | 368.957 $ | |
| 1.376 | Endava PLC | 82.819 | 366.060 $ | |
| 1.377 | Oruka Therapeutics Inc | 7.441 | 364.981 $ | |
| 1.378 | Collegium Pharmaceutical Inc | 10.803 | 357.255 $ | |
| 1.379 | Braemar Hotels & Resorts Inc | 147.995 | 349.268 $ | |
| 1.380 | Trevi Therapeutics Inc | 29.133 | 347.557 $ | |
| 1.381 | Seaport Entertainment Group Inc | 15.891 | 341.339 $ | |
| 1.382 | Xeris Biopharma Holdings Inc | 56.706 | 328.895 $ | |
| 1.383 | EyePoint Inc | 25.464 | 328.231 $ | |
| 1.384 | Palvella Therapeutics Inc | 2.629 | 327.705 $ | |
| 1.385 | Nuvation Bio Inc | 75.811 | 325.229 $ | |
| 1.386 | Zymeworks Inc | 12.788 | 320.212 $ | |
| 1.387 | Tango Therapeutics Inc | 15.210 | 318.193 $ | |
| 1.388 | Pacira BioSciences Inc | 13.968 | 315.677 $ | |
| 1.389 | Amylyx Pharmaceuticals Inc | 22.519 | 313.014 $ | |
| 1.390 | Rapport Therapeutics Inc | 9.773 | 305.797 $ | |
| 1.391 | CareDx Inc | 17.281 | 299.998 $ | |
| 1.392 | Vir Biotechnology Inc | 30.906 | 276.918 $ | |
| 1.393 | Amarin Corp PLC | 18.879 | 272.990 $ | |
| 1.394 | AnaptysBio Inc | 4.784 | 265.321 $ | |
| 1.395 | Tilray Brands Inc | 39.817 | 257.616 $ | |
| 1.396 | Amphastar Pharmaceuticals Inc | 12.564 | 246.129 $ | |
| 1.397 | MannKind Corp | 99.618 | 244.064 $ | |
| 1.398 | Geron Corp | 163.622 | 243.797 $ | |
| 1.399 | Precigen Inc | 60.502 | 234.143 $ | |
| 1.400 | MBX Biosciences Inc | 7.673 | 229.039 $ |